Published in Arch Pediatr Adolesc Med on March 01, 2010
End-of-life decision-making in Canada: the report by the Royal Society of Canada expert panel on end-of-life decision-making. Bioethics (2011) 1.03
Palliative Care as a Standard of Care in Pediatric Oncology. Pediatr Blood Cancer (2015) 0.89
Establishing psychosocial palliative care standards for children and adolescents with cancer and their families: An integrative review. Palliat Med (2015) 0.85
Assessment of the wish to hasten death in patients with advanced disease: A systematic review of measurement instruments. Palliat Med (2016) 0.75
The under reporting of recruitment strategies in research with children with life-threatening illnesses: A systematic review. Palliat Med (2016) 0.75
13% of parents of children who died of cancer considered requesting hastened death for their child: this was more likely if their child was in pain. Evid Based Nurs (2010) 0.75
Symptoms and suffering at the end of life in children with cancer. N Engl J Med (2000) 6.75
Euthanasia and physician-assisted suicide: attitudes and experiences of oncology patients, oncologists, and the public. Lancet (1996) 4.76
Palliative sedation: a review of the research literature. J Pain Symptom Manage (2008) 3.16
Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA (2000) 3.05
Understanding of prognosis among parents of children who died of cancer: impact on treatment goals and integration of palliative care. JAMA (2000) 2.81
Attitudes and desires related to euthanasia and physician-assisted suicide among terminally ill patients and their caregivers. JAMA (2000) 2.62
Desire for euthanasia or physician-assisted suicide in palliative cancer care. Health Psychol (2007) 2.44
Parents' views of cancer-directed therapy for children with no realistic chance for cure. J Clin Oncol (2008) 2.12
Medical end-of-life decisions for children in the Netherlands. Arch Pediatr Adolesc Med (2005) 2.09
Dying and decision making--evolution of end-of-life options. N Engl J Med (2004) 1.86
Parent and physician perspectives on quality of care at the end of life in children with cancer. J Clin Oncol (2005) 1.78
Oregon physicians' attitudes about and experiences with end-of-life care since passage of the Oregon Death with Dignity Act. JAMA (2001) 1.73
Using potentially life-shortening drugs in neonates and infants. Crit Care Med (2000) 1.63
Euthanasia and depression: a prospective cohort study among terminally ill cancer patients. J Clin Oncol (2005) 1.59
Euthanasia and physician-assisted suicide: a review of the empirical data from the United States. Arch Intern Med (2002) 1.58
Palliative treatments of last resort: choosing the least harmful alternative. University of Pennsylvania Center for Bioethics Assisted Suicide Consensus Panel. Ann Intern Med (2000) 1.58
Efficacy and safety of palliative sedation therapy: a multicenter, prospective, observational study conducted on specialized palliative care units in Japan. J Pain Symptom Manage (2005) 1.57
Easing of suffering in children with cancer at the end of life: is care changing? J Clin Oncol (2008) 1.52
Opioid use in last week of life and implications for end-of-life decision-making. Lancet (2000) 1.38
Desire for hastened death in patients with advanced disease and the evidence base of clinical guidelines: a systematic review. Palliat Med (2006) 1.33
Physician-assisted death--from Oregon to Washington State. N Engl J Med (2008) 1.26
Oregonians' reasons for requesting physician aid in dying. Arch Intern Med (2009) 1.25
Public attitudes toward the right to die. CMAJ (1994) 1.16
The desire for hastened death in patients with metastatic cancer. J Pain Symptom Manage (2007) 1.07
Responding to desire to die statements from patients with advanced disease: recommendations for health professionals. Palliat Med (2006) 1.07
Attitudes towards, and wishes for, euthanasia in advanced cancer patients at a palliative medicine unit. Palliat Med (2005) 1.03
The desire for hastened death in individuals with advanced cancer: a longitudinal qualitative study. Soc Sci Med (2009) 0.96
Drugs used to alleviate symptoms with life shortening as a possible side effect: end-of-life care in six European countries. J Pain Symptom Manage (2006) 0.95
Dealing with requests for euthanasia: a qualitative study investigating the experience of general practitioners. J Med Ethics (2008) 0.93
Effects of opioids and sedatives on survival in an Australian inpatient palliative care population. Intern Med J (2005) 0.92
Concerns of family members of patients receiving palliative sedation therapy. Support Care Cancer (2004) 0.88
Family experience with palliative sedation therapy for terminally ill cancer patients. J Pain Symptom Manage (2004) 0.86
Why now? Timing and circumstances of hastened deaths. J Pain Symptom Manage (2005) 0.84
Community attitudes toward physician assisted suicide. Omega (Westport) (2004) 0.81
Critical events in the dying process: the potential for physical and psychosocial suffering. J Palliat Med (2007) 0.80
Who favors legalizing physician-assisted suicide? The vote on Michigan's Proposal B. Politics Life Sci (2001) 0.78
Attitudes of Flemish secondary school students towards euthanasia and other end-of-life decisions in minors. Child Care Health Dev (2009) 0.78
Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol (2004) 7.45
Addressing the ethical challenges in genetic testing and sequencing of children. Am J Bioeth (2014) 7.34
Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2004) 7.02
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. N Engl J Med (2014) 6.67
Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol (2008) 5.61
A randomized study of how physicians interpret research funding disclosures. N Engl J Med (2012) 5.47
Patient Perspectives on the Learning Health System: The Importance of Trust and Shared Decision Making. Am J Bioeth (2015) 5.07
Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet (2004) 4.99
Bench to bedside: mapping the moral terrain of clinical research. Hastings Cent Rep (2008) 4.98
Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol (2003) 4.50
Equipoise and the dilemma of randomized clinical trials. N Engl J Med (2011) 4.34
Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol (2003) 4.24
A phase 3 trial of semagacestat for treatment of Alzheimer's disease. N Engl J Med (2013) 4.11
Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study. BMJ (2014) 3.90
Clinical trials and medical care: defining the therapeutic misconception. PLoS Med (2007) 3.77
Attitudes Toward Risk and Informed Consent for Research on Medical Practices: A Cross-sectional Survey. Ann Intern Med (2015) 3.71
Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions. J Natl Cancer Inst (2012) 3.16
Impact of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol (2002) 3.09
End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol (2010) 2.97
Benefit in phase 1 oncology trials: therapeutic misconception or reasonable treatment option? Clin Trials (2008) 2.94
Pediatric palliative care. N Engl J Med (2004) 2.94
Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA (2010) 2.93
Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study. J Clin Oncol (2013) 2.91
Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol (2011) 2.83
HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis. J Clin Oncol (2004) 2.78
Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care (2005) 2.75
Point-counterpoint. Ethics and genomic incidental findings. Science (2013) 2.73
Views of American oncologists about the purposes of clinical trials. J Natl Cancer Inst (2002) 2.71
American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J Clin Oncol (2008) 2.69
Moving toward quality palliative cancer care: parent and clinician perspectives on gaps between what matters and what is accessible. J Clin Oncol (2012) 2.68
Physicians' attitudes about multiplex tumor genomic testing. J Clin Oncol (2014) 2.62
Paediatric palliative care: challenges and emerging ideas. Lancet (2008) 2.60
Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer. JAMA (2012) 2.56
Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis. J Natl Cancer Inst (2008) 2.56
Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer. J Clin Oncol (2012) 2.53
Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis. J Clin Oncol (2005) 2.52
Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730). J Clin Oncol (2005) 2.48
Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology (2008) 2.37
Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). J Natl Cancer Inst (2006) 2.34
Sharing of clinical trial data among trialists: a cross sectional survey. BMJ (2012) 2.31
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol (2006) 2.29
Patients' views on financial conflicts of interest in cancer research trials. N Engl J Med (2006) 2.29
A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network. Ann Surg (2006) 2.29
Incidental findings in human subjects research: what do investigators owe research participants? J Law Med Ethics (2008) 2.28
Representativeness of participants in the cancer care outcomes research and surveillance consortium relative to the surveillance, epidemiology, and end results program. Med Care (2013) 2.22
Patients' experiences with care for lung cancer and colorectal cancer: findings from the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2010) 2.16
Can research and care be ethically integrated? Hastings Cent Rep (2011) 2.15
Parents' views of cancer-directed therapy for children with no realistic chance for cure. J Clin Oncol (2008) 2.12
Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst (2003) 2.11
Research ethics. Paying patients for their tissue: the legacy of Henrietta Lacks. Science (2012) 2.10
End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med (2012) 2.08
Evaluating the therapeutic misconception. Kennedy Inst Ethics J (2006) 2.06
Experiences and attitudes of genome investigators regarding return of individual genetic test results. Genet Med (2013) 1.97
Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol (2012) 1.95
Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol (2009) 1.94
Treatment decision making in early-stage breast cancer: should surgeons match patients' desired level of involvement? J Clin Oncol (2002) 1.89
Site of oncologic specialty care for older adolescents in Utah. J Clin Oncol (2007) 1.87
Cancer patients' roles in treatment decisions: do characteristics of the decision influence roles? J Clin Oncol (2010) 1.84
Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971. Blood (2011) 1.81
Parent and physician perspectives on quality of care at the end of life in children with cancer. J Clin Oncol (2005) 1.78
The OHRP and SUPPORT. N Engl J Med (2013) 1.78
Discussions with physicians about hospice among patients with metastatic lung cancer. Arch Intern Med (2009) 1.77
Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network. Cancer (2012) 1.75
Caring for the child with cancer at the close of life: "there are people who make it, and I'm hoping I'm one of them". JAMA (2004) 1.75
Hope and prognostic disclosure. J Clin Oncol (2007) 1.73
Relationships between authorship contributions and authors' industry financial ties among oncology clinical trials. J Clin Oncol (2010) 1.73
Use of colony-stimulating factors with chemotherapy: opportunities for cost savings and improved outcomes. J Natl Cancer Inst (2011) 1.71
Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants. J Natl Cancer Inst (2005) 1.70
Selecting high priority quality measures for breast cancer quality improvement. Med Care (2008) 1.70
Medical oncologists' perceptions of financial incentives in cancer care. J Clin Oncol (2012) 1.69
Pediatricians' reports of their education in ethics. Arch Pediatr Adolesc Med (2008) 1.68
Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors. J Clin Oncol (2013) 1.66
Communication about prognosis between parents and physicians of children with cancer: parent preferences and the impact of prognostic information. J Clin Oncol (2006) 1.66
Frequency, type, and monetary value of financial conflicts of interest in cancer clinical research. J Clin Oncol (2007) 1.65
Parental perspectives on suffering and quality of life at end-of-life in children with advanced heart disease: an exploratory study*. Pediatr Crit Care Med (2014) 1.63
Improving the care of children with advanced cancer by using an electronic patient-reported feedback intervention: results from the PediQUEST randomized controlled trial. J Clin Oncol (2014) 1.63
High-cost imaging in elderly patients with stage IV cancer. J Natl Cancer Inst (2012) 1.63
Pediatric palliative care patients: a prospective multicenter cohort study. Pediatrics (2011) 1.63
Peer-delivered smoking counseling for childhood cancer survivors increases rate of cessation: the partnership for health study. J Clin Oncol (2005) 1.61
A unique researcher identifier for the Physician Payments Sunshine Act. JAMA (2011) 1.57
Understanding of prognosis among parents of children with cancer: parental optimism and the parent-physician interaction. J Clin Oncol (2007) 1.56
Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol (2002) 1.55
Chemotherapy drug shortages in pediatric oncology: a consensus statement. Pediatrics (2014) 1.54
Patterns of care at end of life in children with advanced heart disease. Arch Pediatr Adolesc Med (2012) 1.53
Quality of health care for children: role of health and chronic illness in inpatient care experiences. Arch Pediatr Adolesc Med (2007) 1.53
Easing of suffering in children with cancer at the end of life: is care changing? J Clin Oncol (2008) 1.52
Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery? Med Care (2009) 1.51
Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participants. J Natl Cancer Inst (2004) 1.51
Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfaction. J Clin Oncol (2002) 1.49